• DATES: 23-24 September 2023

This conference promises to be an exciting and informative event for all professionals interested in the latest developments in the early detection and management of congenital heart defects (CHD).

The FIRST TRIMESTER ECHOCARDIOGRAPHY & EARLY CHD SCREENING conference, taking place on 23-24th September 2023 in London, will be an extraordinary and unparalleled event. With great pleasure we invite you to attend our annual conference, which will be dedicated entirely to the early fetal heart.

This year’s conference will serve as a comprehensive summary of the groundbreaking work we have accomplished in developing and promoting first-trimester CHD screening worldwide. Our extensive training program has gained immense popularity and widespread implementation.

This state-of-the-art conference in London promises an exciting exploration of the latest advancements. In just two days, you will gain all the essential knowledge about early fetal echocardiography and CHD. The conference will provide practical insights, techniques, and guidance for early diagnosis, verification, counseling, diagnostic work-up, and management of congenital heart defects (CHD). We will present an efficient and pragmatic approach to the early fetal scan, combining practicality with cutting-edge methodologies.

We look forward to seeing you at this exciting event and sharing the latest knowledge and advancements in early CHD screening and management.

Created and delivered by Dr Fred Ushakov

The program is based on extensive clinical experience, comprehensive research of current literature and evidence based knowledge.

Early diagnosis and management of congenital heart defects:

• 12 reasons why screening for CHD at 10-11 or 12-14 weeks is preferable to at 20 weeks

• First-trimester screening for CHD and Early Echocardiography: what is the difference?

• Role of fetal cardiologist in early detection of CHD: working together

• Meta-analysis and systematic review: Performance of CHD screening (2022)

• FMF publications on CHD screening

• Updated ISUOG Practice Guidelines: Performance of 11-14-week ultrasound scan (2023)

• Early screening for CHD and referral pathways

• 10 weeks CHD screening: New approach and future pathways

• SlowflowHD: Revolution in Doppler imaging

• ISUOG guidelines on ultrasound safety: urgent need for correction

• NT, DV, TR and other surrogate markers: their role in CHD screening

• The technique of cardiac examination at 10-11 and 12-14 weeks

• Transabdominal and transvaginal cardiac scan

• Common patterns of CHD in the 1st trimester

• Missed TGA in the first trimester: Lessons from mistakes

• Common CHD: All the spectrum

• Rare CHD: Dozens of unusual cardiac anomalies

• CHD detectable only in the 1st trimester

• Main limitations of cardiac scan at 10-14 weeks

• Human genetic and early detection of CHD

• 22q11 deletion screening

• Role of exome in CHD

• Management of pregnancy with early diagnosis of CHD

• 4 clinical scenarios of CHD presentation

• How to implement 1st trimester CHD screening in the UK and worldwide?

The event will include:

• Important anomalies case discussions

• Videos

• Live Q&A

* Please note that the final program will be published later.